Terug
Dagbereik
€ 438,42
€ 449,14
52-Weeksbereik
€ 265,00
€ 615,00
Volume
197.756
50D / 200D Gem.
€ 468,57
/
€ 437,29
Vorige Slotkoers
€ 447,72
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -35,4 | 0,3 |
| P/B | 16,9 | 2,9 |
| ROE % | -42,5 | 3,7 |
| Net Margin % | -30,1 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 705,67
+58.6%
Low: € 527,00
High: € 964,00
Forward WPA
-€ 4,49
Omzet Sch.
1,5 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 70,33
€ 59,58 – € 79,31
|
4,9 B | 4 |
| FY2029 |
€ 49,53
€ 41,96 – € 55,85
|
3,9 B | 4 |
| FY2028 |
€ 31,37
€ 16,07 – € 49,15
|
3 B | 11 |
Belangrijkste Punten
Negative free cash flow of -190,02M
Capital efficient — spends only 0,05% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)432,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-42,49%
ROIC-23,52%
Net Margin-30,08%
Op. Margin-31,31%
Veiligheid
Debt / Equity
0,59
Current Ratio4,01
Interest Coverage-13,45
Waardering
P/E Ratio
-35,41
P/B Ratio16,94
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 432,05% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 958,40M | Net Income (TTM) | -288,28M |
| ROE | -42,49% | ROA | -22,89% |
| Gross Margin | 94,14% | Operating Margin | -31,31% |
| Net Margin | -30,08% | Free Cash Flow (TTM) | -190,02M |
| ROIC | -23,52% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,59 | Current Ratio | 4,01 |
| Interest Coverage | -13,45 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -35,41 | P/B Ratio | 16,94 |
| P/S Ratio | 10,65 | PEG Ratio | 1,10 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 10,21B | Enterprise Value | 10,36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 958,40M | 180,13M | 0,0 | 0,0 | 0,0 |
| Net Income | -288,28M | -465,89M | -373,63M | -295,35M | -241,85M |
| EPS (Diluted) | -12,85 | -21,90 | -19,99 | -17,23 | -14,63 |
| Gross Profit | 902,26M | 173,90M | 0,0 | 0,0 | 0,0 |
| Operating Income | -300,10M | -497,88M | -380,50M | -293,57M | -242,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,26B | 1,04B | 640,55M | 362,57M | 273,33M |
| Total Liabilities | 656,90M | 287,86M | 235,21M | 165,18M | 77,23M |
| Shareholders' Equity | 602,69M | 754,38M | 405,33M | 197,39M | 196,11M |
| Total Debt | 354,36M | 119,57M | 117,19M | 49,89M | 797.000,0 |
| Cash & Equivalents | 198,69M | 100,02M | 99,92M | 331,55M | 36,27M |
| Current Assets | 1,25B | 1,03B | 637,28M | 361,37M | 271,68M |
| Current Liabilities | 310,29M | 169,28M | 118,55M | 115,89M | 76,84M |